DOCSLIB.ORG

Irb Infrastructure Developers Limited

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Preliminary Placement Document Subject to Completion any Not for Circulation any in to Serial Number:_____ or Strictly Confidential Shares public Equity the IRB INFRASTRUCTURE DEVELOPERS LIMITED to the (Incorporated on July 27, 1998 in the Republic of India with limited liability having corporate identity number L65910MH1998PLC115967 under the Companies Act, 1956) buy offer Our Company is issuing up to [●] equity shares of face value of ₹ 10 each (the “Equity Shares”) at a price of ₹ [●] per Equity Share (the “Issue Price”), including a premium of ₹ or an [●] per Equity Share, aggregating up to ₹ [●] million (the “Issue”). to not ISSUE IN RELIANCE UPON CHAPTER VIII OF THE is SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2009, AS AMENDED (THE “SEBI REGULATIONS”) AND SECTION 42 OF THE COMPANIES ACT, 2013, READ WITH RULE 14 OF THE COMPANIES (PROSPECTUS AND and ALLOTMENT OF SECURITIES) RULES, 2014, EACH AS AMENDED subscribe to le purpose of inviting Bids for the Equity Shares Shares Equity the for Bids inviting of purpose le basis The Equity Shares are listed on BSE Limited (the “BSE”) and National Stock Exchange of India Limited (the “NSE”, and together with the BSE, the “Stock Exchanges”). The closing prices of the Equity Shares on the BSE and the NSE as at March 19, 2015 was ₹ 233.60 and ₹ 234.35 per Equity Share, respectively. In-principle approvals under Clause 24(a) offer of the Listing Agreement (as defined hereinafter) for listing of the Equity Shares have been received from both the BSE and the NSE on March 19, 2015. Applications are expected to an be made for obtaining the listing and trading approvals in relation to the Equity Shares to be expected to be issued in connection with the Issue to the Stock Exchanges. The Stock Exchanges assume no responsibility for the correctness of any statements made, opinions expressed or reports contained herein. Admission of the Equity Shares to be issued pursuant placement to the Issue for trading on the Stock Exchanges should not be taken as an indication of the merits of our Company, its business or the Equity Shares. soliciting private OUR COMPANY HAS PREPARED THIS PRELIMINARY PLACEMENT DOCUMENT SOLELY FOR PROVIDING INFORMATION IN CONNECTION WITH not a THE PROPOSED ISSUE. is on A copy of this Preliminary Placement Document (which includes disclosures prescribed under Form PAS-4 (as hereinafter defined)) has been delivered to the Stock Exchanges, and a and copy of the Placement Document (which shall include disclosures prescribed under Form PAS-4) is expected to be delivered to the Stock Exchanges. Our Company shall also make QIBs the requisite filings with the Registrar of Companies, Maharashtra, at Mumbai (the “RoC”), and the Securities and Exchange Board of India (“SEBI”), each within the stipulated period as required under the Companies Act, 2013 and the Companies (Prospectus and Allotment of Securities) Rules, 2014. This Preliminary Placement Document has not been Shares ed. pany and is being issued for the so the for issued being is and pany reviewed by SEBI, the Reserve Bank of India (the “RBI”), the Stock Exchanges, the RoC or any other regulatory or listing authority and is intended only for use by the eligible Eligible qualified institutional buyers (“Eligible QIBs”, as defined hereinafter). This Preliminary Placement Document has not been and will not be registered as a prospectus with the RoC, will not be circulated or distributed to the public in India or any other jurisdiction, and will not constitute a public offer in India or any other jurisdiction. Equity for THE DISTRIBUTION OF THIS PRELIMINARY PLACEMENT DOCUMENT IS BEING MADE TO ELIGIBLE QIBs IN RELIANCE UPON SECTION 42 OF THE any only COMPANIES ACT, 2013, READ WITH RULE 14 OF THE COMPANIES (PROSPECTUS AND ALLOTMENT OF SECURITIES) RULES, 2014, AND CHAPTER VIII sell OF THE SEBI REGULATIONS. THIS PRELIMINARY PLACEMENT DOCUMENT IS PERSONAL TO EACH PROSPECTIVE INVESTOR AND DOES NOT to CONSTITUTE AN OFFER OR INVITATION OR SOLICITATION OF AN OFFER TO THE PUBLIC OR TO ANY OTHER PERSON OR CLASS OF INVESTORS meant WITHIN OR OUTSIDE INDIA OTHER THAN TO ELIGIBLE QIBs. is offer This Preliminary Placement Document (which includes disclosures prescribed under Form PAS-4) will be circulated only to such Eligible QIBs whose names are recorded by the an Company prior to making an invitation to subscribe to the Equity Shares. Issue not YOU MAY NOT AND ARE NOT AUTHORISED TO (1) DELIVER THIS PRELIMINARY PLACEMENT DOCUMENT TO ANY OTHER PERSON; OR (2) The is REPRODUCE THIS PRELIMINARY PLACEMENT DOCUMENT IN ANY MANNER WHATSOEVER; OR (3) RELEASE ANY PUBLIC ADVERTISEMENT OR UTILISE ANY MEDIA, MARKETING OR DISTRIBUTION CHANNELS OR AGENTS TO INFORM THE PUBLIC AT LARGE ABOUT THE ISSUE. ANY DISTRIBUTION OR REPRODUCTION OF THIS PRELIMINARY PLACEMENT DOCUMENT IN WHOLE OR IN PART IS UNAUTHORISED. FAILURE TO COMPLY WITH THIS INSTRUCTION MAY RESULT IN A VIOLATION OF THE SEBI REGULATIONS OR OTHER APPLICABLE LAWS OF INDIA AND/OR changed. Document OTHER JURISDICTIONS. be INVESTMENTS IN EQUITY SHARES INVOLVE A HIGH DEGREE OF RISK AND PROSPECTIVE INVESTORS SHOULD NOT INVEST IN THE ISSUE UNLESS may THEY ARE PREPARED TO TAKE THE RISK OF LOSING ALL OR PART OF THEIR INVESTMENT. PROSPECTIVE INVESTORS ARE ADVISED TO CAREFULLY READ THE SECTION “RISK FACTORS” INCLUDED IN THIS PRELIMINARY PLACMENT DOCUMENT AND EXPECTED TO BE INCLUDED IN Placement and THE PLACEMENT DOCUMENT BEFORE MAKING AN INVESTMENT DECISION RELATING TO THE EQUITY SHARES IN ISSUE. EACH PROSPECTIVE INVESTOR IS ADVISED TO CONSULT ITS OWN ADVISORS ABOUT THE PARTICULAR CONSEQUENCES OF AN INVESTMENT IN THE EQUITY SHARES BEING ISSUED PURSUANT TO THE PLACEMENT DOCUMENT. complete Invitations for subscription of the Equity Shares to be issued pursuant to the Issue shall only be made pursuant to the Placement Document together with the Application Form (as Preliminary hereinafter defined) and the Confirmation of Allocation Note (as hereinafter defined). For further details, see the section “Issue Procedure”. The distribution of this Preliminary not Placement Document or the disclosure of its contents without our Company’s prior consent to any person, other than Eligible QIBs and persons retained by Eligible QIBs to advise is This them with respect to their purchase of Equity Shares, is unauthorised and prohibited. Each prospective investor, by accepting delivery of this Preliminary Placement Document, permitted. agrees to observe the foregoing restrictions and make no copies of this Preliminary Placement Document and/or any of the documents referred to in this Preliminary Placement Document. not is Shares. The Equity Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold within Document the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S (“Regulation S”) under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold (a) in Equity the United States only to persons who are qualified institutional buyers (as defined in Rule 144A under the Securities Act (“Rule 144A”) and referred to in this Preliminary Placement Document as “U.S. QIBs”; for the avoidance of doubt, the term U.S. QIBs does not refer to a category of institutional investors defined under applicable Indian regulations subscription Placement the and referred to in this Preliminary Placement Document as “Eligible QIBs”), and (b) outside the United States in offshore transactions as defined in and in reliance on Regulation S. or Prospective purchasers in the United States are hereby notified that we are relying on the exemption under Section 4(a)(2) of the Securities Act. The Equity Shares are transferable only in accordance with the restrictions described under “Transfer Restrictions”. For further details, see sections “Selling Restrictions” and “Transfer Restrictions”. sale purchase The information on our Company’s website, any website directly or indirectly linked to our Company’s website, or the website of the Book Running Lead Managers or their to Preliminary respective affiliates does not form part of this Preliminary Placement Document and prospective investors should not rely on such information contained in, or available through, any offer, such websites. this This Preliminary Placement Document is dated March 19, 2015 such in BOOK RUNNING LEAD MANAGERS investors where of class information EMKAY GLOBAL FINANCIAL SERVICES LIMITED ICICI SECURITIES LIMITED other jurisdiction The IDFC SECURITIES LIMITED Com the of Shares Equity the purchase to person any to offer public a not constitute does Document Placement Preliminary This be chang and may complete not is Document Placement this Preliminary in information The this Issue. to pursuant offered being TABLE OF CONTENTS NOTICE TO INVESTORS ............................................................................................................................ 1 REPRESENTATIONS BY INVESTORS ...................................................................................................... 3 OFFSHORE DERIVATIVE INSTRUMENTS .............................................................................................. 8 DISCLAIMER CLAUSE OF THE STOCK EXCHANGES ........................................................................
Recommended publications
  • By Thesis Submitted for the Degree of Vidyavachaspati (Doctor of Philosophy) Faculty for Moral and Social Sciences Department Of

    By Thesis Submitted for the Degree of Vidyavachaspati (Doctor of Philosophy) Faculty for Moral and Social Sciences Department Of

    “A STUDY OF AN ECOLOGICAL PATHOLOGICAL AND BIO-CHEMICAL IMPACT OF URBANISATION AND INDUSTRIALISATION ON WATER POLLUTION OF BHIMA RIVER AND ITS TRIBUTARIES PUNE DISTRICTS, MAHARASHTRA, INDIA” BY Dr. PRATAPRAO RAMGHANDRA DIGHAVKAR, I. P. S. THESIS SUBMITTED FOR THE DEGREE OF VIDYAVACHASPATI (DOCTOR OF PHILOSOPHY) FACULTY FOR MORAL AND SOCIAL SCIENCES DEPARTMENT OF SOCIOLOGY TILAK MAHARASHTRA VIDHYAPEETH PUNE JUNE 2016 CERTIFICATE This is to certify that the entire work embodied in this thesis entitled A STUDY OFECOLOGICAL PATHOLOGICAL AND BIOCHEMICAL IMPACT OF URBANISATION AND INDUSTRILISATION ON WATER POLLUTION OF BHIMA RIVER AND Its TRIBUTARIES .PUNE DISTRICT FOR A PERIOD 2013-2015 has been carried out by the candidate DR.PRATAPRAO RAMCHANDRA DIGHAVKAR. I. P. S. under my supervision/guidance in Tilak Maharashtra Vidyapeeth, Pune. Such materials as has been obtained by other sources and has been duly acknowledged in the thesis have not been submitted to any degree or diploma of any University or Institution previously. Date: / / 2016 Place: Pune. Dr.Prataprao Ramchatra Dighavkar, I.P.S. DECLARATION I hereby declare that this dissertation entitled A STUDY OF AN ECOLOGICAL PATHOLOGICAL AND BIO-CHEMICAL IMPACT OF URBANISNTION AND INDUSTRIALISATION ON WATER POLLUTION OF BHIMA RIVER AND Its TRIBUTARIES ,PUNE DISTRICT FOR A PERIOD 2013—2015 is written and submitted by me at the Tilak Maharashtra Vidyapeeth, Pune for the degree of Doctor of Philosophy The present research work is of original nature and the conclusions are base on the data collected by me. To the best of my knowledge this piece of work has not been submitted for the award of any degree or diploma in any University or Institution.
  • Life and Death in the Times Of

    Life and Death in the Times Of

    2020 i COMMONWEALTH HUMAN RIGHTS INITIATIVE The Commonwealth Human Rights Initiative (CHRI) is an independent, non-governmental, non-profit organisation headquartered in New Delhi, India, with offices in London, United Kingdom, and Accra, Ghana. Since 1987, it has advocated, engaged and mobilised around human rights issues in Commonwealth countries. Its specialisations in the areas of Access to Justice (ATJ) and Access to Information (ATI) are widely known. The ATJ programme has focussed on Police and Prison Reforms, to reduce arbitrariness and ensure transparency while holding duty bearers to accountability. CHRI looks at policy interventions, including legal remedies, building civil society coalitions and engaging with stakeholders. The ATI programme looks at Right to Information (RTI) LIFE AND DEATH IN THE TIME OF RTI and Freedom of Information laws across geographies, provides specialised advice, sheds light on challenging issues and processes for widespread use of transparency laws and develops capacity. We review pressures on media and CASE STUDIES FROM MAHARASHTRA media rights while a focus on Small States seeks to bring civil society voices to bear on the UN Human Rights Council and the Commonwealth Secretariat. A new area of work is SDG 8.7 whose advocacy, research and mobilisation across geographies is built on tackling contemporary forms of slavery. CHRI has special consultative status with the UN Economic and Social Council and is accredited to the Commonwealth Secretariat. Recognised for its expertise by governments, oversight bodies and civil society, CHRI is registered as a society in India, a limited charity in London and an NGO in Ghana. Although the Commonwealth, an association of 54 nations, provided member countries the basis of shared an investigative report by common laws, there was little specific focus on human rights issues in member countries.

  • The Anti- SEZ Movement in India

    THE ANTI-SEZ MOVEMENT IN INDIA An Account of the Struggle in Maharashtra Dr. Sampat Kale About NCAS National Centre for Advocacy Studies (NCAS) is a membership based social change resource center working with social action groups, public interest professionals and citizens from all over South Asia. Presently based in Pune, NCAS began its work in 1992 with the aim of empowering people working towards changing the social fabric of India for a just and humane society. It is an autonomous membership based organisation registered under the Societies Registration Act, 1860 and the Bombay Public Trusts Act, 1950. The centre has been promoted by more than fifty credible grassroots organisations and social action groups from different regions of India. NCAS is a pro-active learning organisation that works towards w a participatory, rights based and people-centred policy environment, w a transparent and accountable governance and w advancement of human rights, equitable social change and distributive justice. The mission of NCAS is to create an enabling environment for social action groups, social change agents and citizens w to get access to democratic institutions and w to effectively advocate the rights of the marginalised sections (women, tribals, dalits and labourers in the unorganised sector) so as to empower them. As a social change resource centre, NCAS endeavours w to strengthen the capacity of people and social action groups to advocate on issues of basic rights and public interest, and facilitate democratic processes w by extending capacity building, information, research and campaign inputs. A group of committed social activists guide the working of NCAS.
  • Souvenir Annual Report 2015-2016 Regd

    Souvenir Annual Report 2015-2016 Regd

    SAMPARC Social Action for Manpower Creation SOUVENIR ANNUAL REPORT 2015-2016 REGD. OFFICE SAMPARC Balgram, Village Bhaje, Malavli Rly. Stn, Tal. Maval, Dist. Pune, Maharashtra, India – 410405. Varad Apartments, 292, Yashwant Nagar, Near Rly.Stn, Talegaon-Dabhade, Tal.Maval, Dist.Pune, Maharashtra, India - 410 507 Tel:.- +91-02114-227335,Mob:+91 9766343456 E-mail:[email protected]; www.samparc-india.org SAMPARC ANNUAL REPORT 2015-2016 INDEX A Walk for 27 - 11 2016 1. Kindly Visit Us 02 Railway stn. Malavli, Near Lonavla 2. SAMPARC Governing Council 03 3. Vision, Mission and Objectives of SAMPARC 04 Glory of Maharashtra 4. SAMPARC Annual Report 2015-2016 05 5. To Corporate and Professionals 45 Walk for Fun, Health and Heritage 6. SAMPARC Founder Members 46 Cell No. : 9766343456 / 9890707737 Email : [email protected] 7. SAMPARC Life Members 46 Walk start from footstap of Bhaje Cave 27th November 2016. At 08.00 AM 8. SAMPARC General Members & Endowment Funds 47 9. Members of Local Level Managing Committee 48 10. Our Partners and Main Donors 50 11. SAMPARC Brand Ambassador 51 Join with family and friends 12. List of Sponsors 52 13. Credibility Alliance 54 to join 14. Awards & Recognition 55 a walk for total 7.2 KM Up and Down, Welcome by community people, maharashtrian food flavour (For the cause of orphan children and community) Samparc Heritage Walk Welcome Register for Heritage Walk through website : www.samparcheritagewalk.com Take back good memory of Bhaje Budhist Caves, Visapur Fort, Lohgad Pavna Dam etc. archaeological monuments. 1 S AMP 2 AR C ANNU SAMPARC Amber Project, VTC for Youth Girls & Womer, Village Khajurol, Tahsil-Chunar, Dist-Mirzapur, UP Mob: 8543915727 AL REPOR T 2015-2016 Child & Family Counseling Centre/ Sr.
  • District Census Handbook, Poona

    District Census Handbook, Poona

    CENSUS OF INDIA 1961 DISTRICT CENSUS HANDBOOK POONA Compiled by THE MAHARASHTRA CENSUS OFFICE BOMBAY Printed in India by the Manager. Gmunment Press and Book Depot. Nagpur, and Published by the Director, Government Printing and Stationery. Maharashtra State, Bombay-4 1966 [ Price - Rs. Eight] CENSUS OF INDIA 1961 Central Government Publications ~Census Report, Volume X-Maharashtra, is published in the following Parts I-A and B General Report I-C Subsidiary Tables II-A General Population Tables II-B (i) General Economic Tables-Industrial Classification II-B (ii) General Economic Tables-Occupational Classification II-C (i) Social and Cultural Tables II-C (ii) Migration Tables III Household Economic Tables IV Report on Housing and Establishments V-A Scheduled Castes and Scheduled Tribes in Maharashtra-­ Tables V-B Scheduled Castes and Scheduled Tribes in Maharashtra­ Ethr.ographic Notes VI (1-35) Village Surveys (35 m0nographs on 35 sdected villages) VII-A (1-8) Handicrafts in Maharashtra (8 monogfaphs on 8 selected handicrafts) VII-B Fairs and Festivals in Maharashtra VIII-A Administration Report-Enumeration (For official use only) VIII-B Administration Report-Tabulation (For official use only) IX Census Atlas of Maharashtra X (1-12) Cities of Maharashtra (15 Volumes-Four volumes on Greater Bombay and One each 01\ other eleven Cities) State Government Publications 25 Volumes of District Census Handbooks in English 25 Volumes of District Census Handbooks in Marathi Alphabetical List .. ; -villages in Maharashtra J-I 076-i-D (Poona). II) ; t (/ l: ~ j b u - ~ ~ « a:: I •• 0"" z fjl'o~<'; 0 f­ ({ ~ ~ Z 1(1 » z ~ 0(.
  • Ie-Pune-06-12-2020.Pdf

    Ie-Pune-06-12-2020.Pdf

    eyeeye THESUNDAY EXPRESSMAGAZINE AWRITER’S PUNE,LATECITY REVOLT DECEMBER6,2020 Acampaignofhatebrought 16PAGES,`5.00 Perumal Murugan, SHareesh to mainstream attention DAILYFROM: AHMEDABAD,CHANDIGARH, DELHI, JAIPUR, KOLKATA, LUCKNOW, MUMBAI, NAGPUR, PUNE, VADODARA WWW.INDIANEXPRESS.COM PAGES 13,14,15 OFFER TO AMENDLAWSTURNED DOWN Cleared in UK, Pfizer Farmershardenstance,Govtweighs first in India to apply for emergency use options,Housesessionnotruledout an application on December 4to PAYALBANERJEE the DCGI seeking emergency use NEWDELHI,DECEMBER5 authorisation(EUA) forits Covid- As unions insist 19 vaccine," asource said. "The PFIZER INDIA has become the firm has submitted the EUAap- on repealoflaws, firstpharmaceutical firm to seek plication in Form CT-18for grant Govt says will from the Drugs Controller of permission to importand ‘The3farm General of India (DCGI) emer- market Pfizer-BioNTech'sCovid- getbackwith gency use authorisation forits 19 mRNAvaccineBNT162b2in laws are Covid-19vaccine in the country, the country,"the source said, cit- proposalonDec 9 afterits parent companysecured ing the application. suchclearance in the UK and VKPaul, who chairs the neither helpful Bahrain. high-levelNational Expert HARIKISHANSHARMA In itsapplication to thedrug Group on Vaccine for farmers &LIZMATHEW regulator,Pfizer has sought per- Administration, had earlier NEWDELHI,DECEMBER5 missiontoimportthe vaccine for spelledout India’s strategy with nor consumers’ sale and distribution in the coun- respect to candidates likePfizer THE CENTRAL government try, besides waiver of clinical tri- and Moderna whichhaveshown found itself hemmedinon als on Indian population in ac- positive resultsinPhase III Saturday withfarmerunions cordance with the special abroad but arenot being tested once again taking amaximalist provisionsunderthe NewDrugs here. “Weknowthat doses of Raju Shetti position demandingarepealof and Clinical Trials Rules, 2019,of- this vaccine (Pfizer) will notbe all three farm laws.